← Leaderboards
Xiaowu Liang
Immport Therapeutics, Inc.
$1,118,920
Attributed
$1,418,920
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $300K · FY2008–16$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,418,920 · 3
By mechanism
R43$1,418,920 · 3
Top collaborators
- Abraham P Lee2 shared
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesAntigensProteinsBaseInfectionSpottingsSerumStagingProtein MicrochipsCommunicable DiseasesProteomicsSerologicalEvaluationDiagnosticPlasmodium FalciparumGenomicsAntibodiesMalariaImmunityPreclinical StudyDiagnosisDesignGenerationsProteome
Grant awards (5)
A NOVEL IMMUNO-PROTEOMIC APPROACH TO A GENITAL HERPES VACCINE$224,911
R43 · FY2016 · AI · contact PI
Integrated Microfluidic Platform for Point-of-Care Serodiagnostics$300,000
R43 · FY2013 · AI · contact PI
Integrated Microfluidic Platform for Point-of-Care Serodiagnostics$300,000
R43 · FY2012 · AI · contact PI
Antibodies to malaria blood stages in mixed-species infections$294,009
R43 · FY2009 · AI · contact PI
Antibodies to malaria blood stages in mixed-species infections$300,000
R43 · FY2008 · AI · contact PI